AnPac Bio-Medical Science Co., Ltd. Sees Large Drop in Short Interest

ANPCDelisted Stock  USD 4.37  0.20  4.38%   
About 62% of Anpac Bio's investor base is looking to short. The analysis of current outlook of investing in Anpac Bio Medical suggests that many traders are alarmed regarding Anpac Bio's prospects. The current market sentiment, together with Anpac Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Anpac Bio Medical stock news signals to limit their universe of possible portfolio assets.
  
AnPac Bio-Medical Science Co., Ltd. was the recipient of a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 37,500 shares, a decline of 38.1 percent from the January 31st total of 60,600 shares. Based on an average trading volume of 32,700

Read at thelincolnianonline.com
news
  

Anpac Bio Fundamental Analysis

We analyze Anpac Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anpac Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anpac Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Anpac Bio is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Anpac Bio Medical Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Anpac Bio stock to make a market-neutral strategy. Peer analysis of Anpac Bio could also be used in its relative valuation, which is a method of valuing Anpac Bio by comparing valuation metrics with similar companies.

Peers

Anpac Bio Related Equities

PMVPPmv Pharmaceuticals   4.32   
0%
17.0%
MRKRMarker Therapeutics   4.00   
0%
16.0%
LUMOLumos Pharma   1.86   
0%
7.0%
AVTEAerovate Therapeutics   1.14   
0%
4.0%
ANEBAnebulo Pharmaceuticals   0.70   
0%
2.0%
OPTOpthea   0.54   
0%
2.0%
ALRNAileron Therapeutics   0.35   
1.0%
0%
CELCCelcuity LLC   1.33   
5.0%
0%
ACRVAcrivon Therapeutics,   1.85   
7.0%
0%
ABVCABVC Biopharma   1.89   
7.0%
0%
HOWLWerewolf Therapeutics   2.00   
8.0%
0%
ANTXAN2 Therapeutics   4.19   
17.0%
0%
EWTXEdgewise Therapeutics   4.42   
18.0%
0%
CCCCC4 Therapeutics   5.49   
22.0%
0%
PTIXProtagenic Therapeutics   20.34   
83.0%
0%
XCURExicure   24.38   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Consideration for investing in Anpac Stock

If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bonds Directory
Find actively traded corporate debentures issued by US companies
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope